Arteris, INC Form 4 insider transactions

Director Saiyed Atiq Raza sold 41,439 shares of Arteris, Inc. common stock at an average price of $10.3655, as part of a pre-arranged 10b5-1 trading plan.

Director Saiyed Atiq Raza sold a total of 27,083 shares of Arteris, Inc. common stock in two transactions on December 17 and 18, 2024, under a pre-arranged 10b5-1 trading plan.

Arteris CEO Charles Janac sold a total of 26,801 shares of common stock in two transactions on December 17th and 18th, 2024, under a pre-arranged 10b5-1 trading plan.

Arteris CEO Charles Janac sold a total of 65,509 shares of common stock in two transactions on December 13th and 16th, 2024, under a pre-arranged 10b5-1 trading plan.

Arteris Inc. director Saiyed Atiq Raza sold a total of 68,249 shares of common stock in two transactions under a pre-arranged 10b5-1 trading plan.

Arteris director Saiyed Atiq Raza sold a total of 19,350 shares of common stock in two transactions on December 11 and 12, 2024, under a pre-arranged 10b5-1 trading plan.

Arteris CEO Charles Janac sold a total of 20,256 shares of common stock on December 11th and 12th, 2024, under a pre-arranged 10b5-1 trading plan.

Director Wayne C. Cantwell of Arteris Inc. sold a total of 5,000 shares of common stock over two days under a pre-arranged 10b5-1 trading plan.

Arteris, Inc.'s CFO, Nicholas B. Hawkins, sold 722 shares of common stock at $9.30 per share on December 5, 2024, under a pre-arranged 10b5-1 trading plan.

Director Isabelle F. Geday of Arteris, Inc. sold 15,550 shares of common stock at an average price of $9.0325 per share on December 4, 2024, under a pre-arranged 10b5-1 trading plan.

Arteris Inc.'s VP and General Counsel, Paul L. Alpern, sold a total of 683 shares of common stock on December 3rd and 5th, 2024, to cover tax liabilities and under a pre-arranged trading plan.

Arteris Inc.'s Chief Operating Officer, Laurent R. Moll, sold shares to cover tax liabilities and under a pre-arranged trading plan.

Arteris CEO Charles Janac sold a total of 3,303 shares of common stock on December 3rd and 4th, 2024, to cover tax liabilities and under a pre-arranged trading plan.

Arteris Inc.'s CFO, Nicholas B. Hawkins, sold a total of 10,437 shares of common stock between December 2nd and December 4th, 2024, under a pre-arranged 10b5-1 trading plan.

Arteris director Antonio J. Viana transferred 5,071 common shares to the Viana Family Trust, while also receiving 5,071 shares from the trust.

Nicholas Hawkins, CFO of Arteris, Inc., sold 19,299 shares of common stock at an average price of $8.1377 on November 6, 2024, under a pre-arranged 10b5-1 trading plan.

Director Antonio J. Viana of Arteris, Inc. sold 2,781 shares of common stock at an average price of $6.8377 on November 1, 2024, under a pre-arranged 10b5-1 trading plan.

Director Joachim Kunkel acquired 312 shares of Arteris, Inc. common stock as retainer fees in lieu of cash on October 5, 2024.

Director Antonio J. Viana acquired 2,580 shares of Arteris, Inc. common stock as fully vested restricted stock in lieu of cash retainer fees.

Paul Alpern, VP and General Counsel of Arteris, Inc., sold 3,615 shares of common stock at an average price of $7.1302 per share under a pre-arranged 10b5-1 trading plan.

Nicholas Hawkins, CFO of Arteris, Inc., sold 4,958 shares of common stock at an average price of $7.1301 on October 4, 2024, under a pre-arranged 10b5-1 trading plan.

Laurent R. Moll, Chief Operating Officer of Arteris, Inc., sold shares of common stock to cover tax liabilities arising from the release of restricted stock units.

Arteris, Inc. CEO Charles Janac sold shares of company stock on October 2nd and 3rd, 2024, to cover tax liabilities and as part of a pre-arranged trading plan.

Paul Alpern, VP and General Counsel of Arteris, Inc., sold shares of common stock on October 2, 2024, to cover tax liabilities arising from the release of restricted stock units.

Nicholas Hawkins, CFO of Arteris Inc., sold shares of common stock on October 1st and 2nd, 2024, under a pre-arranged 10b5-1 trading plan.

Director Joachim Kunkel reports acquiring 40,096 shares of Arteris, Inc. common stock through restricted stock units.

Laurent R. Moll, Chief Operating Officer of Arteris, Inc., sold shares of common stock to cover tax liabilities arising from the release of restricted stock units.

Director Wayne C. Cantwell sold 15,000 shares of Arteris, Inc. common stock on September 6, 2024, under a pre-arranged 10b5-1 trading plan.

Arteris, Inc. CEO Charles Janac sold 1,955 shares of common stock at an average price of $7.2587 on September 5, 2024, under a pre-arranged 10b5-1 trading plan.

Laurent R. Moll, Chief Operating Officer of Arteris, Inc., sold shares of common stock on September 4th and 5th, 2024, to cover tax liabilities related to the release of restricted stock units.